- Filed
- May 29, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding restated | Q1 2024 · May 17, 2024 | 1.48B sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 1.46B sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 1.46B sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$113.48K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$144.02K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $678.12K |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $930.7K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $2.48M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $2.71M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $466.52K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $231.94K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $481.43K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $275.61K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $844.18K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $835.98K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.16M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.21M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $85.44K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $82.08K |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $22.19K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $26.78K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$252.58K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$226.26K |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$124.22K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$220.98K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $44.29K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $12.08K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $13.59K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $73.58K |
| Revenue | Q1 2024 · Mar 31, 2024 | $57.88K |
| Revenue | Q1 2024 · Mar 31, 2023 | $85.66K |
| Capex | Q1 2024 · Mar 31, 2023 | $128.45K |